|
Market Cap (18-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 10 June 2022, 8:25. The announcement is not marked as price sensitive, and is 32 page(s) in length and 2.82MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 3.521% short sold according to ASIC data. It was ranked the 66th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Presentation to Jefferies Global Healthcare Conference | 10 June 2022, 8:25 |
| Telix receives AUD$17.25 million R&D tax refund | 7 June 2022, 8:27 |
| App 3Y Change in Director interests - T Olson | 6 June 2022, 8:23 |
| Leadership changes including Darren Smith appointment as CFO | 1 June 2022, 8:24 |
You must be logged in to post a reply.
Telix Pharmaceuticals 